Adaptive Biotechnologies (ADPT) Non-cash Items (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Non-cash Items data on file, last reported at $35.9 million in Q1 2026.

• Quarterly Non-cash Items rose 567.99% year-over-year to $35.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.9 million (up 567.99% YoY) and the FY2025 annual result came in at $56982.0, down 97.36% from the prior year.
• Non-cash Items rose to $35.9 million in Q1 2026 per ADPT's latest filing, from $56982.0 in the prior quarter.
• The five-year high for Non-cash Items was $51.6 million in Q1 2022, with the low at $56982.0 in Q4 2025.
• Average Non-cash Items over 5 years is $10.6 million, with a median of $4.2 million recorded in 2022.
• Year-over-year, Non-cash Items plunged 99.21% in 2024 and jumped 24370.0% in 2025.
• Adaptive Biotechnologies' Non-cash Items stood at $6.7 million in 2022, then tumbled by 92.39% to $506000.0 in 2023, then jumped by 326.28% to $2.2 million in 2024, then sank by 97.36% to $56982.0 in 2025, then jumped by 62863.74% to $35.9 million in 2026.
• Business Quant data shows ADPT's Non-cash Items at $35.9 million in Q1 2026, $56982.0 in Q4 2025, and $15.4 million in Q3 2025.